Combined chemotherapy based on bioactive black phosphorus for pancreatic cancer therapy.

[1]  Chenxi Liu,et al.  Prognosis and survival analysis of patients with pancreatic cancer: retrospective experience of a single institution , 2022, World Journal of Surgical Oncology.

[2]  D. Dawe,et al.  Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy , 2021, American journal of clinical oncology.

[3]  Yongkai Yuan,et al.  Surface coating of zein nanoparticles to improve the application of bioactive compounds: A review , 2021, Trends in Food Science & Technology.

[4]  Jian Liu,et al.  Combination of anlotinib and gemcitabine promotes the G0/G1 cell cycle arrest and apoptosis of intrahepatic cholangiocarcinoma in vitro , 2021, Journal of clinical laboratory analysis.

[5]  Guofang Zhang,et al.  Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase , 2021, Nature Nanotechnology.

[6]  Hao Hu,et al.  The Influence of Cell Cycle Regulation on Chemotherapy , 2021, International journal of molecular sciences.

[7]  Lian-Hua Fu,et al.  Biodegradable Calcium Phosphate Nanotheranostics with Tumor‐Specific Activatable Cascade Catalytic Reactions‐Augmented Photodynamic Therapy , 2021, Advanced Functional Materials.

[8]  M. Pistello,et al.  Protopine/Gemcitabine Combination Induces Cytotoxic or Cytoprotective Effects in Cell Type-Specific and Dose-Dependent Manner on Human Cancer and Normal Cells , 2021, Pharmaceuticals.

[9]  R. Laforest,et al.  CC Chemokine Receptor 2-Targeting Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma. , 2021, ACS nano.

[10]  P. Chu,et al.  Complete ablation of resistant tumors with photosensitive black phosphorus quantum dots-based lipid nanocapsules , 2020 .

[11]  P. Chu,et al.  Calcium Phosphate Mineralized Black Phosphorous with Enhanced Functionality and Anticancer Bioactivity , 2020, Advanced Functional Materials.

[12]  Zhuxian Zhou,et al.  Enzyme-Triggered Transcytosis of Dendrimer-Drug Conjugate for Deep Penetration into Pancreatic Tumors. , 2020, ACS nano.

[13]  O. Farokhzad,et al.  ROS-Mediated Selective Killing Effect of Black Phosphorus: Mechanistic Understanding and its Guidance for Safe Biomedical Applications. , 2020, Nano letters.

[14]  P. Chu,et al.  Bioactive phospho-therapy with black phosphorus for in vivo tumor suppression , 2020, Theranostics.

[15]  C. Yue,et al.  Alginate/chitosan-coated zein nanoparticles for the delivery of resveratrol , 2019, Journal of Food Engineering.

[16]  Yanping Cao,et al.  Fabrication of stable zein nanoparticles coated with soluble soybean polysaccharide for encapsulation of quercetin , 2019, Food Hydrocolloids.

[17]  P. Chu,et al.  Black Phosphorus: Bioactive Nanomaterials with Inherent and Selective Chemotherapeutic Effects. , 2018, Angewandte Chemie.

[18]  C. Sette,et al.  Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death. , 2018, Oncology reports.

[19]  Chen Jiang,et al.  Sequentially Triggered Nanoparticles with Tumor Penetration and Intelligent Drug Release for Pancreatic Cancer Therapy , 2018, Advanced science.

[20]  Lei Zheng,et al.  Current Standards of Chemotherapy for Pancreatic Cancer. , 2017, Clinical therapeutics.

[21]  B. Buszewski,et al.  Zinc oxide nanoparticles: Synthesis, antiseptic activity and toxicity mechanism. , 2017, Advances in colloid and interface science.

[22]  Shui-Fang Jin,et al.  Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials. , 2017, Hepatobiliary & pancreatic diseases international : HBPD INT.

[23]  M. Prato,et al.  Few-Layer Graphene Kills Selectively Tumor Cells from Myelomonocytic Leukemia Patients. , 2017, Angewandte Chemie.

[24]  Han Zhang,et al.  Black Phosphorus Nanosheets as a Robust Delivery Platform for Cancer Theranostics , 2017, Advanced materials.

[25]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[26]  W. Jusko,et al.  Pharmacodynamic Modeling of Cell Cycle Effects for Gemcitabine and Trabectedin Combinations in Pancreatic Cancer Cells , 2016, Front. Pharmacol..

[27]  A. Carrato,et al.  Post-gemcitabine therapy for patients with advanced pancreatic cancer - A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens. , 2016, Cancer treatment reviews.

[28]  P. Chu,et al.  Surface Coordination of Black Phosphorus for Robust Air and Water Stability. , 2016, Angewandte Chemie.

[29]  T. Masaki,et al.  Mechanism of gemcitabine-induced suppression of human cholangiocellular carcinoma cell growth. , 2015, International journal of oncology.

[30]  P. Chu,et al.  Ultrasmall Black Phosphorus Quantum Dots: Synthesis and Use as Photothermal Agents. , 2015, Angewandte Chemie.

[31]  M. Eblan,et al.  Clinical Translation of Nanomedicine. , 2015, Chemical reviews.

[32]  B. Li,et al.  Self-assembled zein-sodium carboxymethyl cellulose nanoparticles as an effective drug carrier and transporter. , 2015, Journal of materials chemistry. B.

[33]  Mohammad Asadi,et al.  High‐Quality Black Phosphorus Atomic Layers by Liquid‐Phase Exfoliation , 2015, Advanced materials.

[34]  F. Roviello,et al.  Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study , 2015, Cancer Chemotherapy and Pharmacology.

[35]  Yangchao Luo,et al.  Zein‐based micro‐ and nano‐particles for drug and nutrient delivery: A review , 2014 .

[36]  S. Barni,et al.  Polychemotherapy or gemcitabine in advanced pancreatic cancer: a meta-analysis. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[37]  T. Conroy,et al.  Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  V. Préat,et al.  RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. , 2012, Molecular pharmaceutics.

[39]  J. Gómez-Estaca,et al.  Formation of zein nanoparticles by electrohydrodynamic atomization: Effect of the main processing variables and suitability for encapsulating the food coloring and active ingredient curcumin , 2012 .

[40]  O. Takeuchi,et al.  Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines , 2012, Anti-cancer drugs.

[41]  T. Maekawa,et al.  Biocompatible fluorescent zein nanoparticles for simultaneous bioimaging and drug delivery application , 2012 .

[42]  Liang Liu,et al.  Preparation, characterization, and in vitro release investigation of lutein/zein nanoparticles via solution enhanced dispersion by supercritical fluids , 2012 .

[43]  Bo Zhang,et al.  RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy , 2012, Cancer biology & therapy.

[44]  Jing Zhang,et al.  Surviving cells after treatment with gemcitabine or 5-fluorouracil for the study of de novo resistance of pancreatic cancer. , 2012, Cancer letters.

[45]  Pierre Michel,et al.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. , 2011, The New England journal of medicine.

[46]  Leone Spiccia,et al.  Nanomaterials: Applications in Cancer Imaging and Therapy , 2011, Advanced materials.

[47]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[48]  Xing‐dong Zhang,et al.  Fabrication, biological effects, and medical applications of calcium phosphate nanoceramics , 2010 .

[49]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[50]  Q. Zhong,et al.  Zein nanoparticles produced by liquid-liquid dispersion. , 2009 .

[51]  F. Innocenti,et al.  Clinical pharmacology and pharmacogenetics of gemcitabine , 2009, Drug metabolism reviews.

[52]  J. Au,et al.  Evaluation of Combination Chemotherapy , 2004, Clinical Cancer Research.

[53]  G. Peters,et al.  Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines. , 1999, European journal of cancer.

[54]  L. Hertel,et al.  Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine). , 1990, Cancer research.